Dachaigh › Melanoma › Nebraska › Omaha
Sgrùdaidhean clionaigeach Melanoma ann an Omaha, NE
Tha 12 sgrùdaidhean airson Melanoma a’ lorg phàirtichean aig làraichean ann agus timcheall air Omaha (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
- Alegent Health Immanuel Medical Center, Omaha
- Alegent Health Bergan Mercy Medical Center, Omaha
- Alegent Health Lakeside Hospital, Omaha
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
A’ fastadhÌre 3
- Oncology Hematology West P.C. dba Nebraska Cancer Specialists, Omaha
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
A’ fastadhÌre 2
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medical Center, Omaha
- Nebraska Medicine-Bellevue, Bellevue · 9 mìle air falbh
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
A’ fastadhÌre 3
- Alegent Health Immanuel Medical Center, Omaha
- Alegent Health Bergan Mercy Medical Center, Omaha
- Alegent Health Lakeside Hospital, Omaha
Project: Every Child for Younger Patients With Cancer
A’ fastadhSgrùdadh amharc
- Children's Hospital and Medical Center of Omaha, Omaha
- University of Nebraska Medical Center, Omaha
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
A’ fastadhÌre 1/2
- Nebraska Cancer Specialists, Omaha
Integrated Cancer Repository for Cancer Research
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
- Methodist Estabrook Cancer Center, Omaha
- Nebraska Methodist Health System, Omaha
- University of Nebraska Medical Center, Omaha
- agus 1 a bharrachd
MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
A’ fastadhÌre 1/2
- Nebraska Cancer Specialists, Omaha
Neoadjuvant Darovasertib in Primary Uveal Melanoma
A’ fastadhÌre 3
- TIERING Percentiles, Omaha
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
A’ fastadhSgrùdadh amharc
- Massive Bio SYNERGY-AI site, Omaha
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
A’ fastadhÌre 1/2
- University of Nebraska Medical Center, Omaha
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
A’ fastadh
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medicine, Omaha
- Nebraska Medicine - Bellevue, Bellevue · 9 mìle air falbh
Sgrùdaidhean Melanoma ann am bailtean eile
- Houston, TX59 sgrùdaidhean
- New York City, NY38 sgrùdaidhean
- Los Angeles, CA34 sgrùdaidhean
- Nashville, TN33 sgrùdaidhean
- Pittsburgh, PA31 sgrùdaidhean
- Boston, MA26 sgrùdaidhean
- Philadelphia, PA23 sgrùdaidhean
- San Francisco, CA22 sgrùdaidhean
- Columbus, OH21 sgrùdaidhean
- Durham, NC21 sgrùdaidhean
- Atlanta, GA21 sgrùdaidhean
- Salt Lake City, UT21 sgrùdaidhean
Sgrùdaidhean eile ann an Omaha
- Aillse Prostata27 sgrùdaidhean
- Aillse Sgamhain Neo-chealla-beag24 sgrùdaidhean
- Aillse a' bhroilleach22 sgrùdaidhean
- Aillse (gach seòrsa)18 sgrùdaidhean
- Aillse colorectal18 sgrùdaidhean
- Myeloma iomaill16 sgrùdaidhean
- Cancer Ovarian14 sgrùdaidhean
- Liomfoma Neo-Hodgkin14 sgrùdaidhean
- Cancer Pancreatic14 sgrùdaidhean
- Ailse metastatach13 sgrùdaidhean
- Carcinoma Cealla Sgamach a' Chinn agus a' Mhuineil13 sgrùdaidhean
- Fàilligeadh a' Chridhe13 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.